Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopamine-lesioned rats

被引:35
作者
Dziewczapolski, G
Murer, G
Agid, Y
Gershanik, OS
RaismanVozari, R
机构
[1] CONSEJO NACL INVEST CIENT & TECN, INST INVEST FARMACOL, RA-1033 BUENOS AIRES, DF, ARGENTINA
[2] HOP LA PITIE SALPETRIERE, INSERM, U289, F-75651 PARIS 13, FRANCE
关键词
6-hydroxydopamine; L-DOPA therapy; Parkinson's disease; tyrosine hydroxylase;
D O I
10.1097/00001756-199703030-00031
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
WE investigated the effects of 6 months' oral treatment with L-dihydroxy-phenylalanine (L-DOPA)/carbidopa on the remaining dopaminergic neurones of the substantia nigra pars compacta (SNC) and the ventral tegmental area (VTA) of rats with moderate or severe 6-hydroxydopamine (6-OHDA)-induced lesions and sham-operated animals. Using a radioimmunohistochemical method we counted tyrosine hydroxylase (TH)-radioimmunoreactive cells in the SNC and the VTA in emulsion-coated sections and measured the remaining surface area of both structures on autoradiograms. The sole difference observed was a significant increase of the remaining surface area of TH radioimmunolabelling in the SNC of moderately lesioned rats treated with L-DOPA/carbidopa compared with the untreated animals, while the rest of the parameters recorded, in both structures and groups of animals, were unchanged. This suggest that in vivo, this treatment is not toxic either to healthy dopaminergic neurones of the ventral mesencephalon or to those surviving after a 6-OHDA lesion.
引用
收藏
页码:975 / 979
页数:5
相关论文
共 25 条
[1]   HYPERACTIVITY OF REMAINING DOPAMINERGIC NEURONS AFTER PARTIAL DESTRUCTION OF NIGRO-STRIATAL DOPAMINERGIC SYSTEM IN RAT [J].
AGID, Y ;
JAVOY, F ;
GLOWINSKI, J .
NATURE-NEW BIOLOGY, 1973, 245 (144) :150-151
[2]  
BLANCHARD V, 1995, J NEUROCHEM, V64, P1669
[3]   Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra [J].
Blanchard, V ;
Anglade, P ;
Dziewczapolski, G ;
Savasta, M ;
Agid, Y ;
RaismanVozari, R .
BRAIN RESEARCH, 1996, 709 (02) :319-325
[4]   DOES LEVODOPA AGGRAVATE PARKINSONS-DISEASE [J].
BLIN, J ;
BONNET, AM ;
AGID, Y .
NEUROLOGY, 1988, 38 (09) :1410-1416
[5]   SUPPRESSIVE EFFECT OF L-DOPA ON DOPAMINE CELLS REMAINING IN THE VENTRAL TEGMENTAL AREA OF RATS PREVIOUSLY EXPOSED TO THE NEUROTOXIN 6-HYDROXYDOPAMINE [J].
BLUNT, SB ;
JENNER, P ;
MARSDEN, CD .
MOVEMENT DISORDERS, 1993, 8 (02) :129-133
[6]   THE OCCURRENCE OF MOTOR FLUCTUATIONS IN PARKINSONIAN-PATIENTS TREATED LONG-TERM WITH LEVODOPA - ROLE OF EARLY TREATMENT AND DISEASE PROGRESSION [J].
CARACENI, T ;
SCIGLIANO, G ;
MUSICCO, M .
NEUROLOGY, 1991, 41 (03) :380-384
[7]   EXPANDED DISTRIBUTION OF MESSENGER-RNA FOR NERVE GROWTH-FACTOR, BRAIN-DERIVED NEUROTROPHIC FACTOR, AND NEUROTROPHIN-3 IN THE RAT-BRAIN AFTER COLCHICINE TREATMENT [J].
CECCATELLI, S ;
ERNFORS, P ;
VILLAR, MJ ;
PERSSON, H ;
HOKFELT, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :10352-10356
[8]   EARLY INITIATION OF LEVODOPA TREATMENT DOES NOT PROMOTE THE DEVELOPMENT OF MOTOR RESPONSE FLUCTUATIONS, DYSKINESIAS, OR DEMENTIA IN PARKINSONS-DISEASE [J].
CEDARBAUM, JM ;
GANDY, SE ;
MCDOWELL, FH .
NEUROLOGY, 1991, 41 (05) :622-629
[9]  
COLPAERT FC, 1994, P FABRE MON, P225
[10]   MULTICENTER STUDY OF PARKINSON MORTALITY WITH EARLY VERSUS LATER DOPA TREATMENT [J].
DIAMOND, SG ;
MARKHAM, CH ;
HOEHN, MM ;
MCDOWELL, FH ;
MUENTER, MD .
ANNALS OF NEUROLOGY, 1987, 22 (01) :8-12